Pacemaker induced cardiomyopathy: A register for long term response to CRT

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00012342

Enrollment

Registered

2017-08-04

Start date

2017-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I42.88 Z95.0

Interventions

Group 1: After diagnosis of a Pacemaker-induced cardiomyopathy an optimized chronic heart failure medciation according to the current Guidlines including Sacubitril/Valsartan is performed. After 3 mon

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with PMiCMP from the outpatient clinic (pacing rate over 40% as well as worsening of LV-EF below 35% or below 40% from dyspneoe NYHA II after exclusion other causes)

Exclusion criteria

Exclusion criteria: Rejection of the patient, minor or supervised patients

Design outcomes

Primary

Measure	Time frame
Percentage of CRT responders defined as a reduction in LVESV by more than 15% after 12 months	—

Secondary

Measure	Time frame
Predictors for CRT response after 12 months Adequate ICD therapies after 12 months Improvement of the NYHA stage after 12 months	—

Countries

Germany

Contacts

Public ContactChristoph Melzer

Herzschrittmacher- und ICD-Zentrum Berlin

melzer.implantation@gmail.com030/4482359

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026